Chimeric Therapeutics Ltd stock price live, this page displays ASX CHM stock exchange data. View the CHM premarket stock price ahead of the market session or assess the after hours quote.

Chimeric Therapeutics (ASX:CHM, "Chimeric" or the "Company"), an Australian leader in cell therapy, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational ...

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by stock analysts at Chardan Capital from a “buy” rating to ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by research analysts at William Blair from an “outperform” ...

CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from William Blair analyst Sami Corwin today. The ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by Jefferies Financial Group from a “buy” rating to a “hold ...

CARGO Therapeutics, Inc.’s CRGX share price has dipped by 74.30%, which has investors questioning if this is right time to buy.

Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen ...